Related Experiment Video
Updated: Jan 25, 2026

High-Throughput DNA Plasmid Multiplexing and Transfection Using Acoustic Nanodispensing Technology
Published on: August 8, 2019
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
1ProTherImmune, 3656 Happy Valley Road, Lafayette, CA 94549, USA. Liu@ProTherImmune.com.
Abstract:
This review provides a comparison of the theoretical issues and experimental findings for plasmid DNA and mRNA vaccine technologies. While both have been under development since the 1990s, in recent years, significant excitement has turned to mRNA despite the licensure of several veterinary DNA vaccines. Both have required efforts to increase their potency either via manipulating the plasmid DNA and the mRNA directly or through the addition of adjuvants or immunomodulators as well as delivery systems and formulations. The greater inherent inflammatory nature of the mRNA vaccines is discussed for both its potential immunological utility for vaccines and for the potential toxicity. The status of the clinical trials of mRNA vaccines is described along with a comparison to DNA vaccines, specifically the immunogenicity of both licensed veterinary DNA vaccines and select DNA vaccine candidates in human clinical trials.
Related Concept Videos
Vaccinations
Regulated mRNA Transport
Nuclear Export of mRNA
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

